Early-onset hereditary isolated non-neurogenic orthostatic hypotension in a Swedish family. [PDF]
Clin Auton Res, 2023 Fagius J, Klar J, Dahl N.
europepmc +1 more source
Genetics of Neurogenic Orthostatic Hypotension in Parkinson's Disease, Results from a Cross-Sectional In Silico Study. [PDF]
Brain Sci, 2023 Chevalier G +7 more
europepmc +1 more source
Epidural Spinal Cord Stimulation to Treat Neurogenic Orthostatic Hypotension in Multiple System Atrophy: A New Hope? [PDF]
Mov Disord Clin Pract, 2022 Millar Vernetti P.
europepmc +1 more source
Advances in the Pathophysiology and Management of Supine Hypertension in Patients with Neurogenic Orthostatic Hypotension. [PDF]
Curr Hypertens Rep, 2022 Park JW, Okamoto LE, Biaggioni I.
europepmc +1 more source
Neurogenic Orthostatic Hypotension: a Common Complication of Successful Pancreas Transplantation. [PDF]
Transplant Direct, 2021 Kuten SA +9 more
europepmc +1 more source
Effects of Atomoxetine for the Treatment of Neurogenic Orthostatic Hypotension in Patients With Alpha-synucleinopathies: A Systematic Review of Randomized Controlled Trials and a Focus-Group Discussion. [PDF]
J Clin Neurol, 2023 Jung YJ, Kim A, Okamoto LE, Hong WH.
europepmc +1 more source
Predictors of the Pressor Response to the Norepinephrine Transporter Inhibitor, Atomoxetine, in Neurogenic Orthostatic Hypotension. [PDF]
Hypertension, 2021 Shibao CA +5 more
europepmc +1 more source
The effects of caffeine in adults with neurogenic orthostatic hypotension: a systematic review. [PDF]
Clin Auton Res, 2021 Gibbon JR, Frith J.
europepmc +1 more source
Clinical and neurohormonal characteristics in African Americans with neurogenic orthostatic hypotension. [PDF]
Clin Auton Res, 2021 Giza RJ +4 more
europepmc +1 more source
Safety and efficacy of ampreloxetine in symptomatic neurogenic orthostatic hypotension: a phase 2 trial. [PDF]
Clin Auton Res, 2021 Kaufmann H +7 more
europepmc +1 more source